118 related articles for article (PubMed ID: 16841974)
1. trans-Platinum planar amine compounds with [N2O2] ligand donor sets: effects of carboxylate leaving groups and steric hindrance on chemical and biological properties.
Bulluss GH; Knott KM; Ma ES; Aris SM; Alvarado E; Farrell N
Inorg Chem; 2006 Jul; 45(15):5733-5. PubMed ID: 16841974
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of aqueous solubility and stability employing a trans acetate axis in trans planar amine platinum compounds while maintaining the biological profile.
Ma ES; Bates WD; Edmunds A; Kelland LR; Fojo T; Farrell N
J Med Chem; 2005 Sep; 48(18):5651-4. PubMed ID: 16134932
[TBL] [Abstract][Full Text] [Related]
3. Activation of the trans geometry in platinum antitumor complexes: a survey of the cytotoxicity of trans complexes containing planar ligands in murine L1210 and human tumor panels and studies on their mechanism of action.
Farrell N; Kelland LR; Roberts JD; Van Beusichem M
Cancer Res; 1992 Sep; 52(18):5065-72. PubMed ID: 1516063
[TBL] [Abstract][Full Text] [Related]
4. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.
Benedetti BT; Quintal S; Farrell NP
Dalton Trans; 2011 Nov; 40(41):10983-8. PubMed ID: 21918760
[TBL] [Abstract][Full Text] [Related]
5. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
Brabec V; Christofis P; Slámová M; Kostrhunová H; Nováková O; Najajreh Y; Gibson D; Kaspárková J
Biochem Pharmacol; 2007 Jun; 73(12):1887-900. PubMed ID: 17400194
[TBL] [Abstract][Full Text] [Related]
6. Novel transplatinum(II) complexes with [N2O2] donor sets. Cellular pharmacology and apoptosis induction in Pam 212-ras cells.
Quiroga AG; Pérez JM; Alonso C; Navarro-Ranninger C; Farrell N
J Med Chem; 2006 Jan; 49(1):224-31. PubMed ID: 16392807
[TBL] [Abstract][Full Text] [Related]
7. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
8. New trans-platinum drugs with phosphines and amines as carrier ligands induce apoptosis in tumor cells resistant to cisplatin.
Ramos-Lima FJ; Quiroga AG; García-Serrelde B; Blanco F; Carnero A; Navarro-Ranninger C
J Med Chem; 2007 May; 50(9):2194-9. PubMed ID: 17407274
[TBL] [Abstract][Full Text] [Related]
9. Pyridine-carboxylate complexes of platinum. Effect of N,O-chelate formation on model bifunctional DNA-DNA and DNA-protein interactions.
Quintal SM; Qu Y; Quiroga AG; Moniodis J; Nogueira HI; Farrell N
Inorg Chem; 2005 Jul; 44(15):5247-53. PubMed ID: 16022522
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterisation of mixed ligand Pt(II) and Pt(IV) oxadiazoline complexes.
Sarju J; Arbour J; Sayer J; Rohrmoser B; Scherer W; Wagner G
Dalton Trans; 2008 Oct; (39):5302-12. PubMed ID: 18827937
[TBL] [Abstract][Full Text] [Related]
11. Synthetic route to dinuclear platinum(II) complexes [{trans-PtCl(NH3)2}2(mu-L)]2+ (L = aliphatic or heterocyclic diamine) as potential antitumor agents, exploiting the mutual activation of hydroxido ligands and ammonium groups.
Chopard C; Lenoir C; Rizzato S; Vidal M; Arpalahti J; Gabison L; Albinati A; Garbay C; Kozelka J
Inorg Chem; 2008 Oct; 47(20):9701-5. PubMed ID: 18817377
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells.
New EJ; Roche C; Madawala R; Zhang JZ; Hambley TW
J Inorg Biochem; 2009 Aug; 103(8):1120-5. PubMed ID: 19564043
[TBL] [Abstract][Full Text] [Related]
13. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
Peacock AF; Parsons S; Sadler PJ
J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
[TBL] [Abstract][Full Text] [Related]
14. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
Najajreh Y; Khazanov E; Jawbry S; Ardeli-Tzaraf Y; Perez JM; Kasparkova J; Brabec V; Barenholz Y; Gibson D
J Med Chem; 2006 Jul; 49(15):4665-73. PubMed ID: 16854072
[TBL] [Abstract][Full Text] [Related]
15. Promotion of DNA strand breaks, interstrand cross-links and apoptotic cell death in A2780 human ovarian cancer cells by transplatinum planar amine complexes.
Aris SM; Gewirtz DA; Ryan JJ; Knott KM; Farrell NP
Biochem Pharmacol; 2007 Jun; 73(11):1749-57. PubMed ID: 17418817
[TBL] [Abstract][Full Text] [Related]
16. Platinum(IV) analogues of AMD473 (cis-[PtCl2(NH3)(2-picoline)]): preparative, structural, and electrochemical studies.
Battle AR; Choi R; Hibbs DE; Hambley TW
Inorg Chem; 2006 Aug; 45(16):6317-22. PubMed ID: 16878941
[TBL] [Abstract][Full Text] [Related]
17. Influence of amine ligands on the aquation and cytotoxicity of trans-diamine platinum(II) anticancer complexes.
Cubo L; Quiroga AG; Zhang J; Thomas DS; Carnero A; Navarro-Ranninger C; Berners-Price SJ
Dalton Trans; 2009 May; (18):3457-66. PubMed ID: 19381408
[TBL] [Abstract][Full Text] [Related]
18. Solution behaviour and biomolecular interactions of two cytotoxic trans-platinum(II) complexes bearing aliphatic amine ligands.
Cubo L; Casini A; Gabbiani C; Mastrobuoni G; Messori L; Jiménez-Barbero J; Navarro-Ranninger C; Quiroga AG
Chemistry; 2009 Sep; 15(36):9139-46. PubMed ID: 19655350
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
20. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
Roy S; Westmaas JA; Buda F; Reedijk J
J Inorg Biochem; 2009 Sep; 103(9):1278-87. PubMed ID: 19656572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
